Skip to main content
. 2022 Jul 22;2022:3142306. doi: 10.1155/2022/3142306

Figure 1.

Figure 1

OVs as cancer therapy. In order to limit their pathogenicity, viruses that enter human cells need to be genetically engineered to be suitable for oncolytic virotherapy.